Sanofi Extends Aventis Offer To June 30

The extension would just meet Sanofi’s goal to close the Aventis merger in the second quarter. The European Commission approved sale of Arixtra and Fraxiparine to GlaxoSmithKline May 26; FTC decision on merger is pending.